The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36405
StudyName: Eligibility Metastatic Renal Cell Carcinoma NCT02330783
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 11.05.2019
License: Creative Commons BY 4.0

----

Description: 
Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02330783
